SCHEMBL7969459

SCHEMBL7969459

Cc1cc(C(C)(C)C)ccc1Cc1ncc[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 4/20 0.52
ADRA2A P08913 3/20 0.52
ADRA2B P18089 3/20 0.52
ADRA2C P18825 3/20 0.52
HTR1B P28222 3/20 0.52
ADRA1D P25100 2/20 0.52
ADRA1A P35348 2/20 0.52
ADRA1B P35368 2/20 0.52
TAAR1 Q96RJ0 9/20 0.50
HTR1A P08908 3/20 0.44
KDM4E B2RXH2 1/20 0.37
BTK Q06187 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALOX15 P16050 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CHRM2 P08172 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11291001 0.83 TAAR1 (0.54) ADRA2AADRA2BADRA2CTAAR1HTR1A
SCHEMBL8712604 0.81 TAAR1 (0.61) HTR1DADRA2AADRA2BADRA2CHTR1B
SCHEMBL7983164 0.80 TAAR1 (0.63) HTR1DADRA2AADRA2BADRA2CHTR1B
Hydrochloric Acid SCHEMBL7979721 0.80 TAAR1 (0.59) HTR1DADRA2AADRA2BADRA2CHTR1B
SCHEMBL7176858 0.77 TAAR1 (0.48) ADRA2AADRA2BADRA2CTAAR1HTR1A
SCHEMBL1509682 0.76 TAAR1 (0.67) ADRA2AADRA2BADRA2CTAAR1HTR1A
SCHEMBL954941 0.73 TAAR1 (0.54) ADRA2AADRA2BADRA2CTAAR1HTR1A
Oxalic Acid SCHEMBL7979852 0.72 TAAR1 (0.54) HTR1DADRA2AADRA2BADRA2CHTR1B
SCHEMBL11042945 0.72 TAAR1 (0.49) ADRA2AADRA2BADRA2CTAAR1HTR1A
SCHEMBL7981270 0.72 HTR1D (0.47) HTR1DADRA2AADRA2BADRA2CHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6288101-B1 ADMINISTERING COMPOUNDS SUCH AS 2,6-DIMETHYL-4-ISOPROPYLBENZALDEHYDE TO TREAT INDICATIONS WHERE STIMULATION OF SUBTYPES OF THE SEROTONIN RECEPTOR IS IMPLICATED, SUCH AS MIGRAINES VIRGINIA COMMONWEALTH UNIVERSITY 2001-09-11 US claimed
US-6124338-A TREATING MIGRAINE HEADACHE VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-09-26 US claimed
WO-1998012183-A1 IMIDAZOLES WITH SEROTONIN RECEPTOR BINDING ACTIVITY ALLELIX BIOPHARMACEUTICALS INC. (CA) 1998-03-26 WO claimed
US-6288101-B1 ADMINISTERING COMPOUNDS SUCH AS 2,6-DIMETHYL-4-ISOPROPYLBENZALDEHYDE TO TREAT INDICATIONS WHERE STIMULATION OF SUBTYPES OF THE SEROTONIN RECEPTOR IS IMPLICATED, SUCH AS MIGRAINES VIRGINIA COMMONWEALTH UNIVERSITY 2001-09-11 US disclosed
US-6124338-A TREATING MIGRAINE HEADACHE VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-09-26 US disclosed
WO-1998012183-A1 IMIDAZOLES WITH SEROTONIN RECEPTOR BINDING ACTIVITY ALLELIX BIOPHARMACEUTICALS INC. (CA) 1998-03-26 WO disclosed